Treatment recommendations differ significantly within the spectrum of STAT1 deficiency due to the difference in clinical severity, in which hematopoietic stem cell transplant (HSCT) is recommended for those with AR complete STAT1 deficiency, while antimicrobial treatment is generally adequate for AR partial and AD STAT1 deficiency (4). This evidence concerns the gene STAT1 and Alzheimer disease.